MyFamily

MyGenome

MyOme

Harnessing the True Power of Genetics

At MyOme we help families understand their DNA and how it can impact their health and well-being.

help families understand their DNA

Multi-Factorial
Conditions

Estimate your lifetime risk for over 25 common medical conditions that are multi-factorial i.e. depend on a combination of variants across many genes (e.g., certain cardiovascular diseases, cancers, autoimmune and psychiatric conditions).

Single Gene
Analysis

Identify clinically significant variants for over 100 rare / Mendelian conditions (241 genes) that depend on single genes. Help your doctor understand how you respond to certain drugs based on variance in particular genes.

Family
Planning

Leverage the whole genome to reduce the risk of diseases and disease risks being passed from one generation to the next.

Physician Ordered

All tests can be ordered by licensed physicians and genetic counselors are provided so that results can be used to guide your and your family’s healthcare.

MyOme Difference

MyOme is focused on using well-backed scientific findings and innovative approaches to provide you with actionable insights.

DNA

The Whole Genome

We sequence your entire genome not just a small subset, providing almost 10 times more information. This means our analysis includes common and rare DNA variants, and certain structural variants where portions of chromosomes are added, missing or rearranged.

Innovation

Innovation

The MyOme team is continuously exploring new measurement technologies and analysis methods to enable meaningful interventions based on your genetics. We conduct research studies to test these methods and evaluate their ability to bring you actionable findings.

Genetic Risk Scores

Genetic Risk Scores

Genetic risk scores (GRS), also known as polygenic risk scores, are a new way of combining the impact of many variants across the genome. These scores are particularly useful in estimating risk for common conditions like heart disease that are impacted by many genetic factors. Some tests which estimate risk only based on a single variant can be misleading if there are many other relevant variants. 

Embryo Prediction

Embryo Prediction

An example of our unique technology is the ability to reconstruct the entire genome of an embryo, so that one can apply polygenic models and whole genome analysis to embryo selection in IVF.

Contact Us

We are here for you and happy to answer any questions. Contact us at info@myome.com with any questions OR to keep apprised of any development, provide your name and email information.

Contact Us Home 3

About Us

MyOme helps identify genes that cause disease and act based on the latest science. The data is secure, portable and reusable throughout life.

Meet The Team

Donna Hongo, PhD

Head of Quality and Regulatory

Read more

Kate Im, PhD

Human Genetics Lead / Co-Founder

adsadsd a as asd as as

adsadsd a as asd as as

Read more

Akash Kumar, MD, PhD

Medical Affairs/Co-Founder

Read more

Matthew Rabinowitz, PhD

Chairman / Co-Founder

Read more

Oren Schaedel, PhD

Head of Product / Co-Founder

Oren Schaedel, PhD, co-founded MyOme and is MyOme’s Head of Product Development. Oren comes to MyOme with technological leadership experience and deep domain knowledge in statistics, machine learning and bioinformatics. His focus is building technology-driven products and developing analytical techniques to help people turn data into business insights. He has worked on a variety of … Continued

Oren Schaedel, PhD, co-founded MyOme and is MyOme’s Head of Product Development. Oren comes to MyOme with technological leadership experience and deep domain knowledge in statistics, machine learning and bioinformatics. His focus is building technology-driven products and developing analytical techniques to help people turn data into business insights. He has worked on a variety of multi-disciplinary projects and has successfully led interdisciplinary teams.

Oren co-founded BioNetBook, which developed software for visualizing biomedical experiment and workflows, democratizing the access to scientific methods, where he was awarded the Catalyst Grant from Digital Science. At NGX Bio, he built and led the bioinformatics and engineering team responsible for large scale genomics analysis and quality control, web services, process automation, secure data storage, high performance data transmission, and integration with 3rd party applications, and he most recently spent time at Ancestry. Oren received his BS in Molecular Biology from Israel Institute of Technology and his PhD in Biology from Caltech.

Read more

Jonathan Sheena

Board Member and Advisor

Read more

Raghu Venkatapathy

Director Product Engineering

Read more

Investors

Advisors

Stephen Montgomery, PhD

Associate Professor Of Pathology And Genetics

Trevor Hastie, PhD

Professor Of Statistics And Biomedical Data Sciences

Russ B. Altman, MD, PhD

Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and Computer Science